Literature DB >> 12003899

Standards are needed for quality of life clinical trials.

Andrew Bottomley, Fabio Efficace, Peter M Fayers.   

Abstract

Mesh：

Year:  2002        PMID： 12003899      PMCID： PMC1123109          DOI： 10.1136/bmj.324.7346.1156

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The standard of reporting of health-related quality of life in clinical cancer trials.

Authors:  C W Lee; K N Chi
Journal:  J Clin Epidemiol       Date:  2000-05       Impact factor: 6.437

2.  Quality of economic evaluations in health care.

Authors:  Tom Jefferson; Vittorio Demicheli
Journal:  BMJ       Date:  2002-02-09

Review 3.  Reporting on quality of life in randomised controlled trials: bibliographic study.

Authors:  C Sanders; M Egger; J Donovan; D Tallon; S Frankel
Journal:  BMJ       Date:  1998-10-31

Review 4.  Recommendations on health-related quality of life research to support labeling and promotional claims in the United States.

Authors:  D A Revicki; D Osoba; D Fairclough; I Barofsky; R Berzon; N K Leidy; M Rothman
Journal:  Qual Life Res       Date:  2000       Impact factor: 3.440
  4 in total
  4 in total

Review 1.  Health-related quality of life and regulatory issues in the US and Canada.

Authors:  Judith Glennie
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Overcoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry.

Authors:  Fabio Efficace; Jonathan Rees; Peter Fayers; Andrea Pusic; Martin Taphoorn; Elfriede Greimel; Jaap Reijneveld; Katie Whale; Jane Blazeby
Journal:  Health Qual Life Outcomes       Date:  2014-06-06       Impact factor: 3.186

Review 3.  Quality of life assessment and reporting in randomized controlled trials: a study of literature published from Japan.

Authors:  Mariko Naito; Takeo Nakayama; Shunichi Fukuhara
Journal:  Health Qual Life Outcomes       Date:  2004-06-25       Impact factor: 3.186

Review 4.  Review of health-related quality of life data in multiple myeloma patients treated with novel agents.

Authors:  P Sonneveld; S G Verelst; P Lewis; V Gray-Schopfer; A Hutchings; A Nixon; M T Petrucci
Journal:  Leukemia       Date:  2013-06-20       Impact factor: 11.528
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.